Prospective non interventional study of cabozantinib tablets in adults with advanced renal cell carcinoma following prior vascular endothelial growth factor (VEGF)-targeted therapy (Cassiope)

First published 15/12/2017

Last updated 01/03/2024

EU PAS number:

EUPAS19464

Study

Finalised

Documents

Study protocol

Initial protocol

f-fr-60000-001-protocol

English (4.62 MB - PDF)View document

Study results

F-FR-60000-001_CSR Abstract_Redacted (002)

English (2.14 MB - PDF)View document

Study report

F-FR-60000-001_synopsis_06Nov2020

English (185.92 KB - PDF)View document

Other information

Secondary tabs